Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Cardiac Magnetic Resonance Guided Exploration of Heart Failure with Preserved Ejection Fraction

FY 2021-22

Summary
Heart failure is a debilitating, complex, and often terminal disease that effects over half a million Canadians. Despite decades of research, our understanding of a large category of heart failure cases remains poor, while afflicting half of all heart failure patients. Elderly women outnumber men by nearly two to one within this group, and there is presently no therapy that reliably reduces mortality. Only recently have advances in animal modelling of disease made it possible to study this form of heart failure accurately. This advance has highlighted drugs that alter metabolism as a therapy for this patient group. Many foundational questions as to the disease progression over time, the specific roles of sex and/or menopause, and the viability of drugs that target metabolism are yet to be evaluated. Longitudinal studies that track multiple aspects of the disease over a long period can provide valuable insight to address these questions. In particular, magnetic resonance imaging (MRI) applied to the animal heart is an attractive tool. Through cutting edge imaging protocols, MRI can provide information beyond the mere structure of the heart, revealing changes in both the metabolism and blood supply of the heart muscle itself. When applied in combination with standard assessments of cardiac health, a comprehensive understanding of the disease can be unearthed. This work leverages the strength of MRI to establish a clear, sex specific disease trajectory, while also appraising the potential of a metabolic modulator as a therapy. This serves to expand our understanding of early diagnostic targets, establish new treatment options, and safeguard equitable treatment for the affected patient population.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
458288
Name
Troy Aaron
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Cardiac Magnetic Resonance Guided Exploration of Heart Failure with Preserved Ejection Fraction
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Cardiovascular Health; Diabetes; Heart Failure; Hypertension; Magnetic Resonance Imaging; Menopause; Metabolic Syndrome; Metabolism; Women'S Health
Abstract
Heart failure is a debilitating, complex, and often terminal disease that effects over half a million Canadians. Despite decades of research, our understanding of a large category of heart failure cases remains poor, while afflicting half of all heart failure patients. Elderly women outnumber men by nearly two to one within this group, and there is presently no therapy that reliably reduces mortality. Only recently have advances in animal modelling of disease made it possible to study this form of heart failure accurately. This advance has highlighted drugs that alter metabolism as a therapy for this patient group. Many foundational questions as to the disease progression over time, the specific roles of sex and/or menopause, and the viability of drugs that target metabolism are yet to be evaluated. Longitudinal studies that track multiple aspects of the disease over a long period can provide valuable insight to address these questions. In particular, magnetic resonance imaging (MRI) applied to the animal heart is an attractive tool. Through cutting edge imaging protocols, MRI can provide information beyond the mere structure of the heart, revealing changes in both the metabolism and blood supply of the heart muscle itself. When applied in combination with standard assessments of cardiac health, a comprehensive understanding of the disease can be unearthed. This work leverages the strength of MRI to establish a clear, sex specific disease trajectory, while also appraising the potential of a metabolic modulator as a therapy. This serves to expand our understanding of early diagnostic targets, establish new treatment options, and safeguard equitable treatment for the affected patient population.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Troy, Aaron
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~